Centene Corporation (LON:0HVB)
London · Delayed Price · Currency is GBP · Price in USD 32.65
-0.47 (-1.43%)
At close: Sep 15, 2025
Centene Market Cap
Centene has a market cap or net worth of 11.44 billion as of September 17, 2025. Its market cap has decreased by -63.43% in one year.
Market Cap
11.44B
Enterprise Value
13.76B
Revenue
116.55B
Ranking
n/a
PE Ratio
7.63
Stock Price
32.65
Market Cap Chart
Since December 13, 2001, Centene's market cap has increased from 10.73M to 11.44B, an increase of 106,575.06%. That is a compound annual growth rate of 34.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 11.44B | -53.16% |
| Dec 31, 2024 | 24.43B | -21.50% |
| Dec 29, 2023 | 31.12B | -19.25% |
| Dec 30, 2022 | 38.54B | 8.54% |
| Dec 31, 2021 | 35.51B | 39.29% |
| Dec 31, 2020 | 25.49B | 29.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 176.72B |
| GSK plc | 59.31B |
| Haleon | 30.40B |
| Smith & Nephew | 11.87B |
| ConvaTec Group | 4.76B |
| Hikma Pharmaceuticals | 3.58B |
| HUTCHMED (China) | 2.18B |
| Genus | 1.65B |